History of blood transfusion before 1990 is associated with increased risk for cancer mortality independently of liver disease: A prospective long-term follow-up study

Environmental Health and Preventive Medicine

Volumn 15, Issue 3, 2010, Pages 180-187

  Inoue, Yusuke ^a   Wada, Yasuhiko ^b   Motohashi, Yutaka ^c   Koizumi, Akio ^a  

^a KYOTO UNIVERSITY   (Japan)

^b KANSAI ROSAI HOSPITAL   (Japan)

^c AKITA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Blood transfusion; Cancer; Cohort studies; Residence characteristics

Indexed keywords

ADULT; AGED; ALCOHOL CONSUMPTION; ARTICLE; BLOOD TRANSFUSION; CANCER MORTALITY; CANCER RISK; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; FOLLOW UP; HUMAN; JAPAN; LIVER DISEASE; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; MEDICAL HISTORY; PANCREAS CANCER; PROSPECTIVE STUDY; SMOKING;

EID: 77953356359     PISSN: 1342078X     EISSN: 13474715     Source Type: Journal    
DOI: 10.1007/s12199-009-0125-6     Document Type: Article

References (33)

1. Tartter PI. Blood transfusion history in colorectal cancer patients and cancer-free controls. Transfusion. 1988;28:593-596
2. Woolley AL, Hogikyan ND, Gates GA, Haughey BH, Schecht-man KB, Goldenberg JL. Effect of blood transfusion on recurrence of head and neck carcinoma. Retrospective review and meta-analysis. Ann Otol Rhinol Laryngol. 1992;101:724-730
3. Bordin JO, Heddle NM, Blajchman MA. Biologic effects of leukocytes present in transfused cellular blood products. Blood. 1994;84:1703-1721
4. Blajchman MA, Bordin JO. Mechanisms of transfusion-associated immunosuppression. Curr Opin Hematol. 1994;1:457-461
5. Vamvakas EC. Perioperative blood transfusion and cancer recurrence: meta-analysis for explanation. Transfusion. 1995;35:760-768
6. Vamvakas EC. Transfusion-associated cancer recurrence and postoperative infection: meta analysis of randomized, controlled clinical trials. Transfusion. 1996;36:175-186
7. Landers DF, Hill GE, Wong KC, Fox IJ. Blood transfusion-induced immunomodulation. Anesth Analg. 1996;82:187-204.
8. Blumberg N, Heal JM. Immunological tolerance. Science. 1996;272:1408.
9. Blumberg N, Heal JM. Immunomodulation by blood transfusion: an evolving scientific and clinical challenge. Am J Med. 1996;101:299-308.
10. Klein HG. Immunomodulatory aspects of transfusion: a once and future risk? Anesthesiology. 1999;91:861-865
11. Brand A. Immunological aspects of blood transfusions. Blood Rev. 2000;14:130-144
12. Vamvakas EC. WBC-containing allogeneic blood transfusion and mortality: a meta-analysis of randomized controlled trials. Transfusion. 2003;43:963-973
13. Kikuchi S. Japan Collaborative Cohort Study for Evaluation of Cancer. Personal past history and mortality in the Japan Collaborative Cohort Study for Evaluation of Cancer (JACC). Asian Pac J Cancer Prev. 2007;8(Suppl):9-20.
14. Ohno Y, Tamakoshi A, for the JACC Study Group. Japan collaborative cohort study for evaluation of cancer risk sponsored by Monbusho (JACC Study). J Epidemiol. 2001;11:144-150
15. Tamakoshi A, Yoshimura Y, Inaba Y, Ito Y, Watanabe Y, Fukuda K, et al. Profile of the JACC Study. J Epidemiol. 2005;15:S4-8.
16. American Cancer Society. Cancer facts and figures 2005. Atlanta: American Cancer Society; 2005.
17. Ministry of Health, Labour and Welfare of Japan. Annual Reports of The National Vital Statistics 1997, 1998, 1999, 2000, 2001, 2003, 2004, 2005. Tokyo: 1998, 1999, 2000, 2001, 2002, 2004, 2005 and 2006 (in Japanese).
18. Lin Y, Tamakoshi A, Wakai K, Kawamura T, Aoki R, Kojima M, et al. Descriptive epidemiology of pancreatic cancer in Japan. J Epidemiol. 1998;8:52-59
19. International Agency for Research on Cancer (IARC). Monographs on the evaluation of carcinogenic risks to humans, vol 83. Tobacco smoke and involuntary smoking. Lyon: IARC; 2004.
20. Sene D, Limal N, Cacoub P. Hepatitis C virus-associated extra-hepatic manifestations: a review. Metab Brain Dis. 2004;19:3-4.
21. Malaguarnera M, Gargante MP, Risino C, Ranno S, Berretta M, Cannizzaro MA, et al. Hepatitis C virus in elderly cancer patients. Eur J Intern Med. 2006;17:325-329
22. Merryman HT. Transfusion-induced alloimmunization and immunosuppression and the effects of leukocyte depletion. Transfus Med. 1989;3:180-193
23. Aslam R, Speck ER, Kim M, Freedman J, Semple JW. Transfusion-related immunomodulation by platelets is dependent on their expression of MHC class I molecules and is independent of white cells. Transfusion. 2008;48:1778-1786
24. Japanese Red Cross Non-A Non-B Hepatitis Research Group. Effect of screening for hepatitis C virus antibody and hepatitis B virus core antibody on incidence of post-transfusion hepatitis. Lancet. 1991;338:1040-1041
25. Fujino Y, Tamakoshi A, Hoshiyama Y, Mikami H, Okamoto N, Ohno Y, et al. Prospective study of transfusion history and thyroid cancer incidence among females in Japan. Int J Cancer. 2004;112:722-725
26. Kiyosawa K, Umemura T, Ichijo T, Matsumoto A, Yoshizawa K, Gad A, et al. Hepatocellular carcinoma: recent trends carcinoma: recent trends in Japan. Gastroenterology. 2004;127:S17-26.
27. Hill GE, Frawley WH, Griffith KE, Forestner JE, Minei JP. Allogeneic blood transfusion increases the risk of postoperative bacterial infection: a meta-analysis. J Trauma. 2003;54:908-914
28. Shorr AF, Jackson WL. Transfusion practice and nosocomial infection: assessing the evidence. Curr Opin Crit Care. 2005;11:468-472
29. Siemionow M, Agaoglu G. Role of blood transfusion in transplantation: a review. J Reconstr Microsurg. 2005;21:555-563
30. Heiss MM, Mempel W, Jauch KW, Delanoff C, Mayer G, Mempel M, et al. Beneficial effect of autologous blood transfusion on infectious complications after colorectal cancer surgery. Lancet. 1993;342:1328-1333
31. Van de Watering LM, Hermans J, Houbiers JG, van den Broek PJ, Bouter H, Boer F, et al. Beneficial effects of leukocyte depletion of transfused blood on postoperative complications in patients undergoing cardiac surgery: a randomized clinical trial. Circulation. 1998;97:562-568
32. Bilgin YM, van de Watering LM, Eijsman L, Versteegh MI, Brand R, van Oers MH, et al. Double-blind, randomized controlled trial on the effect of leukocyte-depleted erythrocyte transfusions in cardiac valve surgery. Circulation. 2004;109: 2755-2760
33. Dantal J, Hourmant M, Cantarovich D, Giral M, Blancho G, Dreno B, et al. Effect of long-term immunosuppression in kidney-graft recipients on cancer incidence: randomised comparison of two cyclosporin regimens. Lancet. 1998;351:623-628 (Pubitemid 28098444)